Michael Smith Health Research BC 2023 Scholar and Research Trainee Competitions: Applications Now Open

Michael Smith Health Research BC’s Scholar and Research Trainee awards provide funding to support BC’s next generation of health researchers in advancing science and improving the health of British Columbians. Applications are now open for our 2023 competitions...READ MORE

Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System

Kardium Inc. announces the successful first-in-human study of its next generation Globe® Pulsed Field System to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy. Working with Dr. Vivek Reddy* from Mount Sinai Hospital (New York), and Prof. Petr Neužil and Dr. Jan Petrů from Na Homolce Hospital (Prague), the Kardium team successfully treated 38 patients, isolating 100% of the patients’ pulmonary veins using the Globe Pulsed Field System...READ MORE

Nimbus Synergies Expands Investment Team With Its New Associate, Vivian Wang

The Discovery Group is expanding its team by bringing on Vivian Wang as Investment Associate at Nimbus Synergies. Vivian will be joining Nimbus Synergies in a full-time capacity as she completes her MBA from UBC Sauder School of Business...READ MORE

AbbVie Announces Late-Breaking Results from Phase 2 Exploratory NOVA Trial of Novel Investigational Neurotoxin AGN-151607 for the Prevention of Postoperative Atrial Fibrillation in Cardiac Surgery Patients

AbbVie announced new results from its exploratory NOVA phase 2 dose-ranging study evaluating the efficacy and safety of AGN-151607, a novel investigational neurotoxin for the prevention of postoperative atrial fibrillation in cardiac surgery patients...READ MORE

Landmark EMPA-KIDNEY Trial Showed Significant Benefit of Jardiance® in Reducing Kidney Disease Progression or Cardiovascular Death by 28% vs. Placebo in People With Chronic Kidney Disease

EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (CKD). When treated with empagliflozin, the risk of kidney disease progression or cardiovascular death was significantly reduced by 28% vs. placebo...READ MORE

Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 trial in Patients With IGA nephropathy (IGAN) and CHK-336 Preclinical Efficacy Data at the American Society of Nephrology Kidney Week 2022

Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, announced two posters on the BION-1301 and CHK-336 programs being presented at ASN Kidney Week 2022 being held virtually and live in Orlando, Florida...READ MORE

First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder

Clairvoyant Therapeutics, a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased to announce the first patient has been dosed in the company’s Phase 2 clinical trial investigating psilocybin for the treatment of alcohol use disorder...READ MORE

Sernova Receives Authorization to Enroll Second Patient Cohort of Phase 1/2 Trial with Cell Pouch System™ for Type 1 Diabetes

Sernova Corp. announce, in conjunction with the advancement of its ongoing Phase 1/2 clinical trial of the Sernova Cell Pouch System™ for patients with T1D who suffer from hypoglycemia unawareness, the approval of a protocol amendment by the University of Chicago Institutional Review Board and no objections from FDA, allowing the Company to proceed with a strategically optimized protocol reducing the time required for patient treatment while accelerating potential secondary endpoint efficacy achievement with more optimal dosing...READ MORE

PharmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA

PharmAla Biotech announce that it has submitted its pre-IND data meeting package to the US Food and Drug Administration (USFDA) in advance of its pre-IND meeting scheduled for later this month. PharmAla will be requesting FDA feedback on the nonclinical and CMC development plan to support the initial clinical trial for ALA-002...READ MORE

Nimbus Synergies Appoints New Director of Finance

The Discovery Group has appointed Mathew Merritt as Director of Finance, Nimbus Synergies. Mathew will be taking over for Alfred Sequeira, who is retiring in early 2023. Mathew joins after spending over two years at Vancouver based start-up, Bear’s Blooms, as their CFO...READ MORE

Gilead Sciences Appoints Christophe Griolet to Vice President and General Manager in Canada

Gilead Sciences Canada, Inc. announced that Christophe Griolet joined the organization as Vice President and General Manager. In his new role, Griolet will be responsible for leading the commercial organization for Gilead Canada, with a focus on local growth strategies and person-centered approaches...READ MORE

Government of Canada Announces Chair of Independent Expert Panel That Will Review Applications to the Strategic Science Fund

The scientific breakthroughs of tomorrow will be born out of the work that our researchers and innovators are doing. That is why the Government of Canada is committed to supporting, leveraging and protecting Canadian research and science to grow the economy and improve the quality of life of Canadians…READ MORE

Research and Innovation Manager, Data Science

The Research and Innovation Manager, Data Science is a collaborative member of the Research and Innovation team and works seamlessly across the organization. Reporting to the Data Science Lead you will work with the Research and Innovation leadership and the other members of the Data Science team to implement Genome BC's Data Science Strategy. You will engage external partners to catalyze partnerships across the innovation and research ecosystem in BC, consistent with the organization’s mandate. You are one of the main points of contact at Genome BC for funded project teams and you are responsible for monitoring projects to assess progress and maximize outcomes.

LEARN MORE

Account Manager (US Central)

SignalChem is seeking a well-qualified Account Manager (US Central) to join the sales team. The ideal candidate will be an experienced industry professional with a proven track record in scientific sales. The individual must have exceptional people skills and perform well in a team environment. They should also be able to interpret sales metrics and be goal-oriented. Ultimately, the team member should be able to contribute to creating and maintaining good customer relationships as well and proactively pursue business opportunities with academic and industrial customers/clients.

LEARN MORE

Clinical Trial Associate

The Clinical Trial Associate will be an individual responsible for supporting Clinical Operations team members with project-specific support related to the conduct of clinical trials activities. The Clinical Trial Associate will assist the clinical research teams in ensuring the most effective and efficient conduct of clinical research studies by providing administrative and project tracking support.

This position reports to the Executive Director, Trial Operations and will be located in either the Vancouver, BC, Canada or Boston, MA, USA location.

LEARN MORE

Clarivent Medical are developing the Clarivent Bubble Helmet, a non-invasive positive pressure ventilation hood that has been designed to effectively control aerosol and droplet transmission of infectious diseases within healthcare facilities while delivering breathing support and oxygen therapy. This device will allow patients to be treated in closer proximity by limiting the spread of infectious diseases within the hospital. It will decrease the incidents of health care workers and patients getting common noscomal infections such as COVID-19, pneumonia, and influenza. 

Visit Website

Zucara Therapeutics Inc. is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life.

Visit Website